EUVIMEDEUVIMED entdecken
Crossref

Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA

Francisco José Alberola-Amores iD, Jorge Moral-Rubio

Headache: The Journal of Head and Face Pain · 2023

DOI: 10.1111/head.14532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Headache: The Journal of Head and Face Pain, 2023. Verfasst von Francisco José Alberola-Amores und 1 weiteren Autor:innen. Beteiligte Einrichtung: Headache Unit, Department of Neurology, Hospital General Universitario de Elche, Elche, Spain. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Headache Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epicrania fugax (EF) is a primary headache consisting of brief paroxysms of pain, lasting 1–10 s, that move through different nerve territories of one hemicranium with a linear or zigzag trajectory, although there are some clinical variants. Preventive therapy with anti‐seizure medication such as gabapentin and lamotrigine are most commonly used in patients presenting with frequent and non‐remitting attacks. In some cases, greater occipital nerve blockades are used for short‐ or long‐term relief. Here, we report two patients with a paroxysmal EF‐type pain who meet the criteria for EF of the International Classification of Headache Disorders, 3rd edition, with clear triggers and autonomic ocular signs and who failed multiple preventive treatments, but had a sustained response to onabotulinumtoxinA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type AHeadache DisordersHumansHeadachePainGabapentin

Stichwörter der Autor:innen

botulinum toxinepicrania fugaxonabotulinumtoxinA

Substanzen

Botulinum Toxins, Type AGabapentin

Autor:innen und Institutionen

  • Headache Unit, Department of Neurology, Hospital General Universitario de Elche, Elche, Spain.

ORCID-Profile: Francisco José Alberola-Amores

Zitieren

APA

Alberola-Amores, F. J., & Moral-Rubio, J. (2023). Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14532

Vancouver

Alberola-Amores FJ, Moral-Rubio J. Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA. Headache: The Journal of Head and Face Pain. 2023. doi:10.1111/head.14532

BibTeX
@article{AlberolaAmores2023,
  author = {Alberola-Amores, Francisco José and Moral-Rubio, Jorge},
  title = {Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2023},
  doi = {10.1111/head.14532}
}
Kostenlos starten →